Skip to contentA
Axogen, Inc.
A
AXGNAxogen, Inc. Q1 2014 · 10-Q
Revenue$3.14M$3.14M+46.4% vs Q1 2013 Net Income-$4.24M-$4.24MN/M vs Q1 2013 EPS Diluted-$0.24-$0.24N/M vs Q1 2013 Gross Profit$2,436,956+54.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
Operating Cash Flow-$3,150,593N/M Free Cash Flowderived-$3,346,075N/M Margins · derivedGross margin77.7%+3.8 pt vs Q1 2013
Operating margin-95.3%+13.1 pt vs Q1 2013
Net margin-135.1%+25.3 pt vs Q1 2013
ended Mar 31, 2014 · filed Apr 30, 2014 · 30 d after period end